Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors

111In-pentetreotide scintigraphy vs. 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden

(2019) Thomas A. Hope et al.   JOURNAL OF NUCLEAR MEDICINE

A prospective observational study to evaluate the effects of long-acting somatostatin analogs on 68Ga-DOTATATE uptake in patients with neuroendocrine tumors

(2019) Anni Gålne et al.   JOURNAL OF NUCLEAR MEDICINE

Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors

(2019) Akira Toriihara et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients

(2018) Constantin Lapa et al.   Theranostics

177Lu-DOTATATE Therapy in Radioiodine-refractory Differentiated Thyroid Cancer

(2018) Wolfgang Roll et al.   CLINICAL NUCLEAR MEDICINE

Influence of lanreotide on uptake of 68Ga-DOTATATE in patients with neuroendocrine tumours: a prospective intra-patient evaluation

(2018) E. A. Aalbersberg et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors

(2018) Simone Krebs et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy

(2018) Eric Guedj et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

(2017) Murat Fani Bozkurt et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

(2017) Anders Sundin et al.   NEUROENDOCRINOLOGY

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

(2017) Arvind Dasari et al.   JAMA Oncology

68 Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients

(2016) Wolfgang Peter Fendler et al.   JOURNAL OF NUCLEAR MEDICINE

In Vivo Evaluation of 18F-SiFAlin-Modified TATE: A Potential Challenge for 68Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET

(2015) S. Niedermoser et al.   JOURNAL OF NUCLEAR MEDICINE

Clinical applications of Gallium-68

(2013) Sangeeta Ray Banerjee et al.   APPLIED RADIATION AND ISOTOPES

68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT

(2013) A. Kroiss et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography

(2012) Alejandro Sanchez-Crespo   APPLIED RADIATION AND ISOTOPES

Cryptate mediated nucleophilic 18F-fluorination without azeotropic drying

(2011) S. H. Wessmann et al.   NUKLEARMEDIZIN-NUCLEAR MEDICINE

One-Step18F-Labeling of Carbohydrate-Conjugated Octreotate-Derivatives Containing a Silicon-Fluoride-Acceptor (SiFA): In Vitro and in Vivo Evaluation as Tumor Imaging Agents for Positron Emission Tomography (PET)

(2010) Carmen Wängler et al.   BIOCONJUGATE CHEMISTRY